Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History LEXX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics LEXX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Lexaria Bioscience Corp

LEXX
Current price
0.83 USD -0.056 USD (-6.28%)
Last closed 0.88 USD
ISIN US52886N4060
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 17 883 450 USD
Yield for 12 month -71.34 %
1Y
3Y
5Y
10Y
15Y
LEXX
21.11.2021 - 28.11.2021

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. Its DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, creams, lotions, and skin patches; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada. Address: 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.33 USD

P/E Ratio

Dividend Yield

Financials LEXX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures LEXX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+464 278 USD

Last Year

+226 208 USD

Current Quarter

+174 000 USD

Last Quarter

+183 923 USD

Current Year

+459 456 USD

Last Year

+194 708 USD

Current Quarter

+174 000 USD

Last Quarter

+181 203 USD
EBITDA -9 262 950 USD
Operating Margin TTM -1 581.04 %
Price to Earnings
Return On Assets TTM -77.60 %
PEG Ratio
Return On Equity TTM -145.55 %
Wall Street Target Price 6.33 USD
Revenue TTM 525 923 USD
Book Value 0.41 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 20.00 %
Dividend Yield
Gross Profit TTM 523 203 USD
Earnings per share -0.61 USD
Diluted Eps TTM -0.61 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation LEXX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 20.74
Price Sales TTM 34.00
Enterprise Value EBITDA -7.22
Price Book MRQ 2.43

Technical Indicators LEXX

For 52 Weeks

0.82 USD 4.38 USD
50 Day MA 1.00 USD
Shares Short Prior Month 506 748
200 Day MA 1.79 USD
Short Ratio 4.01
Shares Short 516 563
Short Percent 2.88 %